Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Magali Epinat is active.

Publication


Featured researches published by Magali Epinat.


Current Opinion in Pulmonary Medicine | 2003

Superficial vein thrombosis: risk factors, diagnosis, and treatment

Hervé Decousus; Magali Epinat; Karine Guillot; Sara Quenet; Christian Boissier; Bernard Tardy

Superficial vein thrombosis (SVT) risk factors are close to those of venous thromboembolism (VTE). Diagnosis is made in a clinical setting but ultrasonography is useful to eliminate concomitant deep vein thrombosis (DVT). For SVT of the lower limbs, which is the main location, varicose veins represent the principal cause but underlying conditions (e.g.: autoimmune diseases, malignancy or thrombophilia) must be sought in idiopathic, migrant or recurrent SVT and in the absence of varicose veins. Concomitant DVT and pulmonary embolism can occur in approximately 15% and 5% respectively. Historical treatments consist of anti-inflammatory agents plus elastic stockings and, in case of varicose veins, thrombectomy and stripping. Other treatments (anticoagulants, vein ligation) were assessed to limit the VTE risk. A one-month prophylactic dose of low molecular weight heparin plus elastic stockings could be the appropriate strategy in most cases. Other studies are needed before definitive conclusions can be drawn.


Journal of Vascular Surgery | 2003

Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis

Sara Quenet; Silvy Laporte; Hervé Decousus; Alain Leizorovicz; Magali Epinat; Patrick Mismetti

OBJECTIVE Superficial vein thrombosis may be complicated with venous thromboembolism. We examined factors predictive of venous thromboembolism in superficial vein thrombosis, which, to our knowledge, had not been prospectively studied before. DESIGN AND METHODS We performed post hoc analysis of the STENOX trial, a prospective randomized controlled trial that investigated various antithrombotic therapies in 427 hospitalized patients with objectively confirmed symptomatic isolated superficial vein thrombosis. The value of various baseline characteristics as predictive factors of venous thrombotic complications at 3 months was studied with logistic regression. Venous thrombotic complications were defined as deep vein thrombosis or pulmonary embolism, or recurrence or proximal extension of superficial vein thrombosis. RESULTS Venous thrombotic complications occurred in 78 patients. Independent predictive factors for complications were superficial vein thrombosis of recent onset (odds ratio [OR], 3.01; 95% confidence interval [CI], 1.44-6.27), severe chronic venous insufficiency (OR, 2.75; CI, 1.10-6.89), male gender (OR, 2.17; CI, 1.28-3.68), and history of venous thromboembolism (OR, 2.07; CI 1.06-4.04). Deep vein thrombosis or pulmonary embolism occurred in 19 patients. Only severe chronic venous insufficiency was an independent predictor of this complication (OR, 4.50; CI, 1.30-15.61). CONCLUSIONS After symptomatic isolated superficial vein thrombosis, venous thrombotic complications are relatively frequent, and are more likely to occur in men, in patients with a history of venous thromboembolism or with severe chronic venous insufficiency, or in whom superficial vein thrombosis is recent. Knowledge of such predictive factors may be useful for determining appropriate treatment in patients with superficial vein thrombosis and for designing future phase III clinical trials.


Chest | 2007

A Prospective Long-term Study of 220 Patients With a Retrievable Vena Cava Filter for Secondary Prevention of Venous Thromboembolism

Patrick Mismetti; Karine Rivron-Guillot; Sara Quenet; Hervé Decousus; Silvy Laporte; Magali Epinat; Fabrice Guy Barral


European Journal of Radiology | 2014

Brain magnetic resonance imaging findings in cryptogenic stroke patients under 60 years with patent foramen ovale

Claire Boutet; Laure Rouffiange-Leclair; Pierre Garnier; Sara Quenet; Daphné Delsart; Jérôme Varvat; Magali Epinat; Fabien Schneider; Jean-Christophe Antoine; Patrick Mismetti; Fabrice-Guy Barral


Presse Medicale | 2013

Nouveaux anticoagulants oraux dans la fibrillation atriale non valvulaire

Jean-Christophe Lega; Laurent Bertoletti; Stéphane Durupt; Magali Epinat; Patrick Mismetti; Antoine Da Costa; Silvy Laporte


Therapie | 2013

Hémorragies intracrâniennes : épidémiologie et implication des traitements antithrombotiques

Jérôme Varvat; Magali Epinat; Christophe Nuti; Jean-Christophe Antoine; Patrick Mismetti; Pierre Garnier


Revue Neurologique | 2013

Lésions ischémiques cérébrales après un hématome intracérébral

E. Sala; Jérôme Varvat; Magali Epinat; F.-G. Barral; Pierre Garnier


Revue Neurologique | 2013

Tetraparesia with areflexia revealing cerebral venous thrombosis.

S. Exbrayat; Magali Epinat; T. Atroun; J.-P. Camdessanche; Pierre Garnier; Jérôme Varvat


Revue Neurologique | 2012

Une thrombose veineuse cérébrale révélée par une tétraparésie avec aréflexie

Sophie Exbrayat; Jérôme Varvat; Magali Epinat; Jean Philippe Camdessanche; Pierre Garnier


Current Opinion in Internal Medicine | 2003

Superficial vein thrombosis

Hervé Decousus; Magali Epinat; K. Guillot; Sara Quenet; Christian Boissier; Bernard Tardy

Collaboration


Dive into the Magali Epinat's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sara Quenet

Jean Monnet University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge